Literature DB >> 1563783

Interactions between conidia of Aspergillus fumigatus and human complement component C3.

J E Sturtevant1, J P Latgé.   

Abstract

Activation and deposition of C3 on Aspergillus fumigatus conidia have been previously demonstrated. This study investigated in further detail the interactions between complement component C3 and the conidia of A. fumigatus. Immunoblotting and 125I-C3 binding studies showed that C3 deposition was rapid (less than 15 min) and parallel to the formation of iC3b. Immunoblotting experiments identified a 54- to 58-kDa conidial protein which binds human complement component C3 and/or a C3 fragment(s). 125I labeling of the outer layer of the conidia demonstrated that this protein doublet was present on the surface of the spore. The further degradation of C3 to low-molecular-mass fragments (40, 37, and 30 kDa), in the absence of plasma, by intact living conidia and a preparation of the outer conidial wall layer indicated the ability of fungal components to cleave C3. These data suggest that interactions between conidia and C3 are not limited only to deposition via activation of the alternative complement pathway; they also include degradation of bound C3.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1563783      PMCID: PMC257094          DOI: 10.1128/iai.60.5.1913-1918.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

Review 1.  The role of complement in host resistance to systemic fungal infection.

Authors:  R A Calderone; L Linehan
Journal:  Immunol Ser       Date:  1989

2.  Identification of C3d receptors on Candida albicans.

Authors:  R A Calderone; L Linehan; E Wadsworth; A L Sandberg
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

3.  An iC3b receptor on Candida albicans: structure, function, and correlates for pathogenicity.

Authors:  B J Gilmore; E M Retsinas; J S Lorenz; M K Hostetter
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

Review 4.  Complement and bacteria: chemistry and biology in host defense.

Authors:  K A Joiner; E J Brown; M M Frank
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

5.  Beta 1,4-oligoglucosides inhibit the binding of Aspergillus fumigatus conidia to human monocytes.

Authors:  V L Kan; J E Bennett
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226

6.  The iC3b receptor on Candida albicans: subcellular localization and modulation of receptor expression by glucose.

Authors:  M K Hostetter; J S Lorenz; L Preus; K E Kendrick
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

7.  Action of the C3b-inactivator on the cell-bound C3b.

Authors:  S K Law; D T Fearon; R P Levine
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

8.  Candida albicans and Candida stellatoidea, in contrast to other Candida species, bind iC3b and C3d but not C3b.

Authors:  F Heidenreich; M P Dierich
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

9.  Killing of Aspergillus fumigatus spores by human lung macrophages: a paradoxical effect of heat-labile serum components.

Authors:  M D Robertson; K M Kerr; A Seaton
Journal:  J Med Vet Mycol       Date:  1989

10.  C3bi-binding protein on Candida albicans: temperature-dependent expression and relationship to human complement receptor type 3.

Authors:  A Eigentler; T F Schulz; C Larcher; E M Breitwieser; B L Myones; A L Petzer; M P Dierich
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

View more
  33 in total

1.  Early events in macrophage killing of Aspergillus fumigatus conidia: new flow cytometric viability assay.

Authors:  K A Marr; M Koudadoust; M Black; S A Balajee
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

Review 2.  Innate immunity to Aspergillus species.

Authors:  Stacy J Park; Borna Mehrad
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

3.  Expression and identification of a laminin-binding protein in Aspergillus fumigatus conidia.

Authors:  G Tronchin; K Esnault; G Renier; R Filmon; D Chabasse; J P Bouchara
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

Review 4.  A mucormycosis case in a cirrhotic patient successfully treated with posaconazole and review of published literature.

Authors:  Shang-Yi Lin; Po-Liang Lu; Kun-Bow Tsai; Chun-Yu Lin; Wei-Ru Lin; Tun-Chieh Chen; Ya-Ting Chang; Chung-Hao Huang; Chi-Yu Chen; Chung-Chih Lai; Yen-Hsu Chen
Journal:  Mycopathologia       Date:  2012-06-29       Impact factor: 2.574

5.  Diffusible component from the spore surface of the fungus Aspergillus fumigatus which inhibits the macrophage oxidative burst is distinct from gliotoxin and other hyphal toxins.

Authors:  C G Mitchell; J Slight; K Donaldson
Journal:  Thorax       Date:  1997-09       Impact factor: 9.139

Review 6.  Virulence factors of medically important fungi.

Authors:  L H Hogan; B S Klein; S M Levitz
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

7.  Specific interaction of Aspergillus fumigatus with fibrinogen and its role in cell adhesion.

Authors:  P Coulot; J P Bouchara; G Renier; V Annaix; C Planchenault; G Tronchin; D Chabasse
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

8.  The developmentally regulated alb1 gene of Aspergillus fumigatus: its role in modulation of conidial morphology and virulence.

Authors:  H F Tsai; Y C Chang; R G Washburn; M H Wheeler; K J Kwon-Chung
Journal:  J Bacteriol       Date:  1998-06       Impact factor: 3.490

9.  The crucial role of the Aspergillus fumigatus siderophore system in interaction with alveolar macrophages.

Authors:  Markus Schrettl; Oumaima Ibrahim-Granet; Sabrina Droin; Michel Huerre; Jean-Paul Latgé; Hubertus Haas
Journal:  Microbes Infect       Date:  2010-07-24       Impact factor: 2.700

10.  Role of ficolin-A and lectin complement pathway in the innate defense against pathogenic Aspergillus species.

Authors:  Stefan Bidula; Hany Kenawy; Youssif M Ali; Darren Sexton; Wilhelm J Schwaeble; Silke Schelenz
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.